Why is Nath Bio-Genes (India) Ltd ?
1
Weak Long Term Fundamental Strength with a 1.96% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 6.19% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
- PBT LESS OI(Q) At Rs -1.95 cr has Fallen at -158.91%
- PAT(Q) At Rs -0.15 cr has Fallen at -105.5%
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 0.74 cr
3
Stock is technically in a Bullish range
- The technical trend has deteriorated from Bullish on 17-Jun-26 and has generated 3.32% returns since then
- The stocks MACD and KST technical factors are also Bullish
4
With ROCE of 6.5, it has a Very Attractive valuation with a 0.5 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -16.33%, its profits have risen by 0.7% ; the PEG ratio of the company is 8.2
5
Majority shareholders : Non Institution
6
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.84% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -16.33% returns
How much should you hold?
- Overall Portfolio exposure to Nath Bio-Genes should be less than 10%
- Overall Portfolio exposure to Other Agricultural Products should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nath Bio-Genes for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Nath Bio-Genes
-16.33%
-0.40
40.70%
Sensex
-4.95%
-0.37
13.26%
Quality key factors
Factor
Value
Sales Growth (5y)
13.88%
EBIT Growth (5y)
1.96%
EBIT to Interest (avg)
4.33
Debt to EBITDA (avg)
2.42
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.48
Tax Ratio
10.08%
Dividend Payout Ratio
9.85%
Pledged Shares
13.78%
Institutional Holding
0.24%
ROCE (avg)
6.73%
ROE (avg)
6.19%
Valuation Key Factors 
Factor
Value
P/E Ratio
8
Industry P/E
13
Price to Book Value
0.47
EV to EBIT
7.84
EV to EBITDA
7.24
EV to Capital Employed
0.51
EV to Sales
0.85
PEG Ratio
8.17
Dividend Yield
1.20%
ROCE (Latest)
6.53%
ROE (Latest)
5.71%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
9What is working for the Company
NET SALES(Q)
At Rs 65.96 cr has Grown at 78.90%
PAT(9M)
Higher at Rs 40.14 Cr
-14What is not working for the Company
PBT LESS OI(Q)
At Rs -1.95 cr has Fallen at -158.91%
PAT(Q)
At Rs -0.15 cr has Fallen at -105.5%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 0.74 cr
DEBT-EQUITY RATIO(HY)
Highest at 0.23 times
INTEREST(Q)
Highest at Rs 4.54 cr
Loading Valuation Snapshot...
Here's what is working for Nath Bio-Genes
Net Sales - Quarterly
At Rs 65.96 cr has Grown at 78.90%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Here's what is not working for Nath Bio-Genes
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -1.95 cr has Fallen at -158.91%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -0.15 cr has Fallen at -105.5%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Quarterly
Highest at Rs 4.54 cr
in the last five quarters and Increased by 24.04 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.74 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio - Half Yearly
Highest at 0.23 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio